SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Collagen Corp.
CGEN 1.730-2.3%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: starpopper who wrote ()4/29/1997 8:22:00 AM
From: Jonathan Rothschild   of 72
 
It's hard to tell how this stock will open. I'm still awaiting the employment inflation index and the direction of the overall market. I listened in to the conference call. The main positive news was resumption of Contigen shipments. Many investors bought Collagen stock a few years back due to Contigen and they may go back in with expanded reimbursement. Apparently, Bard is suggesting using fewer syringes, which was one reason why they were overstocked. Next year will be very good, with BSX sales, 2 new products and increased ramps, lowered R & D expenses. Yet, this company is difficult for most analysts to understand.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext